SLC2A1 and chronic kidney disease: Overall, decreased Ki-67 expression, as well as prolonged inhibition of VEGF and Glut-1 expression, by long-term administration of CKD-516 + IR, may be due to a sustained hypoxic microenvironment and central tumor necrosis.